Obamacare & generics industry

Is Barack Obama's re-election a boon for the generics industry?

Current Voting

62%

19%

19%

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X